Sigachi Industries Limited (SIGACHI.BO)
INR 52.77
(2.73%)
INR 52.77
(2.73%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2 Billion INR | -2.38% |
| 2022 | 1.39 Billion INR | 24.44% |
| 2021 | 1.11 Billion INR | 51.47% |
| 2020 | 738.38 Million INR | 41.64% |
| 2019 | 521.29 Million INR | 7.41% |
| 2018 | 485.35 Million INR | 12.99% |
| 2017 | 429.56 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 370.81 Million INR | 17.62% |
| 2023 Q3 | 551.81 Million INR | 3.42% |
| 2023 Q2 | 533.55 Million INR | 19.51% |
| 2023 Q4 | 315.27 Million INR | -42.87% |
| 2023 Q1 | 446.45 Million INR | 175.96% |
| 2023 FY | 1.35 Billion INR | -2.38% |
| 2022 Q4 | 161.78 Million INR | -58.37% |
| 2022 Q3 | 388.58 Million INR | -8.91% |
| 2022 Q2 | 426.57 Million INR | 2.82% |
| 2022 Q1 | 414.85 Million INR | 139.82% |
| 2022 FY | 1.39 Billion INR | 24.44% |
| 2021 Q2 | 323.94 Million INR | 20.0% |
| 2021 FY | 1.11 Billion INR | 51.47% |
| 2021 Q4 | 172.98 Million INR | -50.79% |
| 2021 Q3 | 351.51 Million INR | 8.51% |
| 2021 Q1 | 269.95 Million INR | 191.41% |
| 2020 FY | 738.38 Million INR | 41.64% |
| 2020 Q3 | 230.89 Million INR | 4.82% |
| 2020 Q2 | 220.28 Million INR | 43.0% |
| 2020 Q1 | 154.04 Million INR | 0.0% |
| 2020 Q4 | 92.63 Million INR | -59.88% |
| 2019 FY | 521.29 Million INR | 7.41% |
| 2018 FY | 485.35 Million INR | 12.99% |
| 2017 FY | 429.56 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 90.494% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -28.637% |
| Bal Pharma Limited | 770.19 Million INR | -159.971% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 67.676% |
| Medico Remedies Limited | 262.14 Million INR | -663.81% |
| Lasa Supergenerics Limited | 121.02 Million INR | -1554.369% |
| Venus Remedies Limited | 2.18 Billion INR | 8.261% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 432.381% |
| Alpa Laboratories Limited | 188.89 Million INR | -959.998% |
| Nectar Lifesciences Limited | 2.97 Billion INR | 32.63% |
| Shilpa Medicare Limited | 3.54 Billion INR | 43.548% |
| Aarti Drugs Limited | 8.31 Billion INR | 75.923% |
| Lupin Limited | 123.71 Billion INR | 98.382% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 98.706% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.401% |
| Windlas Biotech Limited | 1.33 Billion INR | -49.558% |
| Suven Life Sciences Limited | -200.79 Million INR | 1097.168% |
| Eris Lifesciences Limited | 10.42 Billion INR | 80.797% |
| Valiant Laboratories Limited | -60.66 Million INR | 3400.612% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 91.179% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -132.499% |
| Ipca Laboratories Limited | 29.8 Billion INR | 93.283% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 45.817% |
| Achyut Healthcare Limited | 4.86 Million INR | -41090.763% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.225% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -36.043% |
| RPG Life Sciences Limited | 2.48 Billion INR | 19.36% |
| Mankind Pharma Limited | 44.52 Billion INR | 95.503% |
| Laurus Labs Limited | 24.62 Billion INR | 91.867% |
| Piramal Pharma Limited | 24.47 Billion INR | 91.818% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -112.467% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 95.718% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 92.523% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 97.112% |
| Unichem Laboratories Limited | 4.86 Billion INR | 58.843% |
| Sequent Scientific Limited | 2.97 Billion INR | 32.781% |
| Novartis India Limited | 1.32 Billion INR | -50.899% |
| Wanbury Limited | 1.73 Billion INR | -15.696% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 51.439% |
| Wockhardt Limited | 16.24 Billion INR | 87.671% |
| Themis Medicare Limited | 1.5 Billion INR | -33.139% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -206.821% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 89.807% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 83.895% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 98.776% |
| Divi's Laboratories Limited | 32.44 Billion INR | 93.828% |
| NATCO Pharma Limited | 25.73 Billion INR | 92.22% |
| Gufic Biosciences Limited | 4.16 Billion INR | 51.957% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | 56.29% |
| Ind-Swift Limited | 2.17 Billion INR | 7.836% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 65.367% |
| FDC Limited | 8.33 Billion INR | 75.977% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -938.922% |
| Granules India Limited | 16.79 Billion INR | 88.081% |
| Medicamen Biotech Limited | 495.49 Million INR | -304.098% |
| Alkem Laboratories Limited | 52.29 Billion INR | 96.171% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 67.823% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -13633.362% |
| Brooks Laboratories Limited | 65.62 Million INR | -2951.33% |
| Megasoft Limited | 342.07 Million INR | -485.341% |
| ZIM Laboratories Limited | 1.26 Billion INR | -58.047% |
| Strides Pharma Science Limited | 14.38 Billion INR | 86.084% |
| Neuland Laboratories Limited | 8.24 Billion INR | 75.724% |
| Morepen Laboratories Limited | 6.16 Billion INR | 67.502% |
| Hikal Limited | 3.14 Billion INR | 36.296% |
| Indoco Remedies Limited | 6.04 Billion INR | 66.857% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 65.663% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -222.701% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -184.575% |
| Hester Biosciences Limited | 1.27 Billion INR | -57.208% |